VIP and experimental autoimmune encephalomyelitis: The experimental autoimmune encephalomyelitis (EAE) in mouse is an inflammatory autoimmune demyelinating disease of the central nervous system, which shares similarity to MS pathologically and clinically. Neuropeptide VIP protects against EAE by downregulating the inflammation and T-helper type-1 driven autoreactive response of MS.